ANTI-TUMOR PROPERTIES OF DICKKOPF 3b
AssigneeUniversity of Massachusetts
InventorJACK L. LEONARD
Life of this patent
Estimating the term…
Abstract
The invention relates to novel therapeutic approaches to cancer treatment that exploits tumor suppressor functions of DKK3b by site-specific delivery of DKK3b. Novel therapeutics and methods for treating tumors and cancers utilizing DKK3b tumor suppressor functions are disclosed.
Claims17
(canceled)
(canceled)
(canceled)
(canceled)
A recombinant virus genetically modified to express human DKK3b protein.
A pharmaceutical composition comprising a recombinant virus genetically modified to express human DKK3b protein and a pharmaceutically acceptable carrier.
A pharmaceutical composition comprising human DKK3b protein and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.